Professor Aled Clayton
Prosiectau fel Prif Ymchwiliwr
- Cancer exosomes as drivers of disease progression, targeting exosome biogenesis to halt disease progression (01.01.2014 - 31.12.2016)
- Cancer exosomes control tumour reactive stroma in malignant pleural mesothelioma (01.11.2009 - 31.10.2010)
- Characterising exosome uptake for elucidating their role in cancer progression and as potential drug delivery vectors (01.10.2015 - 01.12.2018)
- Combination treatment modelling for personalised immunotherapy in mesothelioma (01.03.2018 - 31.07.2021)
- Development of the Zetaview instrument (15.05.2016 - 14.08.2016)
Prosiectau fel Cyd-Ymchwiliwr
- An acoustic chip for separating circulating tumour biomarkers for cancer diagnosis and treatment monitoring (01.02.2018 - 31.01.2019)
- Combination treatment modelling for personalised immunotherapy in mesothelioma (01.03.2018 - 31.07.2021)
- Comparative Health Research Outcomes of NOvel Surgery in prostate cancer - IP4 Chronos (01.10.2019 - 30.04.2022)
- Developing a blood-based assay for predicting response to immune checkpoint inhibition in cancer patients (01.01.2020 - 01.03.2023)
- Development of a nanoscale, near-infrared spectroscopy imaging tool for in situ, rapid and label-free analysis of single extracellular vesicles (01.04.2023 - 31.03.2024)